Ovarian Cancer Research Program at the Department of Defense - FY 2023 Appropriations - H.R.8236 - Department of Defense Appropriations Act, 2023
Peer-Reviewed Cancer Program at Department of Defense - FY 2023 Report - Add Endometrial Cancer as a new Peer Reviewed Cancer Program or to the list of eligible cancers - HR 8236 - Department of Defense Appropriations Act, 2023
Ovarian Cancer Research Program at the Department of Defense - FY 2023 Appropriations - Department of Defense Appropriations Act - Senate Dear Colleague Letters and Report Language Submissions
Peer-Reviewed Cancer Program at Department of Defense - FY 2023 Report - Add Endometrial Cancer as its own line-item program for FY 2023 - Senate Dear Colleague Letters and Report Language Submissions
FY 2023 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research - H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Duration: July 1, 2005
to
May 31, 2022
General Issues: Defense , Health Issues , Medicare/Medicaid
Spending: about $1,310,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2005: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2022
Galileo Consulting Group, Inc. terminated an engagement in which they represented Society of Gynecologic Oncologists on July 20, 2022.
Original Filing: 301388390.xml
Lobbying Issues
Ovarian Cancer Research Program at the Department of Defense - FY 2023 Appropriations - H.R.8236 - Department of Defense Appropriations Act, 2023
Peer-Reviewed Cancer Program at Department of Defense - FY 2023 Report - Add Endometrial Cancer as a new Peer Reviewed Cancer Program or to the list of eligible cancers - HR 8236 - Department of Defense Appropriations Act, 2023
Ovarian Cancer Research Program at the Department of Defense - FY 2023 Appropriations - Department of Defense Appropriations Act - Senate Dear Colleague Letters and Report Language Submissions
Peer-Reviewed Cancer Program at Department of Defense - FY 2023 Report - Add Endometrial Cancer as its own line-item program for FY 2023 - Senate Dear Colleague Letters and Report Language Submissions
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2023 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research - H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on April 18, 2022.
Original Filing: 301359470.xml
Lobbying Issues
Ovarian Cancer Research Program at the Department of Defense - FY 2022 Appropriations - HR 4432 - Department of Defense Appropriations Act, 2022 and HR 2471 - Consolidated Appropriations Act of 2022
Peer-Reviewed Cancer Program at Department of Defense - FY 2022 Report - Add Endometrial Cancer to the list of eligible cancers - HR 4432 and HR 2471 - Consolidated Appropriations Act of 2022
Ovarian Cancer Research Program at the Department of Defense - FY 2023 Appropriations - Department of Defense Appropriations Act - Dear Colleague Letters and Report Language Submissions
Peer-Reviewed Cancer Program at Department of Defense - FY 2023 Report - Add Endometrial Cancer as its own line-item program for FY 2023 - Dear Colleague Letters and Report Language Submissions
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research - HR 2471
Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063)
PREVENT HPV Cancers Act (HR 1550)
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Jan. 16, 2022.
Original Filing: 301323615.xml
Lobbying Issues
Ovarian Cancer Research Program at the Department of Defense - FY 2022 Appropriations - HR 4432 - Department of Defense Appropriations Act, 2022
Peer-Reviewed Cancer Program at Department of Defense - FY 2022 Report - Add Endometrial Cancer to the list of eligible cancers - HR 4432
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research
Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063)
PREVENT HPV Cancers Act (HR 1550)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Physician Fee Schedule Payments for 2022 - Update to the Conversion Factor. S. 610 Protecting Medicare and American Farmers from Sequester Cuts Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Oct. 20, 2021.
Original Filing: 301308883.xml
Lobbying Issues
Ovarian Cancer Research Program at the Department of Defense - FY 2022 Appropriations - HR 4432 - Department of Defense Appropriations Act, 2022
Peer-Reviewed Cancer Program at Department of Defense - FY 2022 Report - Add Endometrial Cancer to the list of eligible cancers - HR 4432
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2022 Federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act - Report Language on Gynecologic Cancer and Disparities Research
Jeanette Acosta Invest in Womens Health Act (H.R. 2216/S. 1063)
PREVENT HPV Cancers Act (HR 1550)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Physician Fee Schedule Payments for 2022: Update to the Conversion Factor
Medicare Proposed Physician Fee Schedule Payments for Office-based services - Clinical Labor Update, Reps. Rush and Bilirakis Letter to CMS, meetings with Members of the Ways and Means and Energy and Commerce Committees and Senate Finance Committee
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 20, 2021.
Original Filing: 301291559.xml
Lobbying Issues
H.R. 4432 - Department of Defense Appropriations Act, 2022: Ovarian Cancer Research Program at the Department of Defense; Peer-Reviewed Cancer Program at the Department of Defense: Add Endometrial Cancer to the list of eligible cancers
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- FY 2022 federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act: Report language on gynecological cancer and disparities research
-- H.R. 1319 - American Rescue Plan Act of 2021: COVID-19 policies and funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Physician Fee Schedule Payments for 2022: Update to the Conversion Factor
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on April 20, 2021.
Original Filing: 301266240.xml
Lobbying Issues
FY 2022 Appropriations - Ovarian Cancer Research Program at the Department of Defense; Peer-Reviewed Cancer Program at the Department of Defense: Add Endometrial Cancer to the list of eligible cancers
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- FY 2022 federal research funding for Gynecologic Cancer Research in the Departments of Labor, HHS and Education Appropriations Act: Report language on gynecological cancer and disparities research
-- H.R. 1319 - American Rescue Plan Act of 2021: COVID-19 policies and funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes: Extends a suspension of Medicare sequestration and makes other technical changes to Medicare payments and Medicaid eligibility
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on Jan. 20, 2021.
Original Filing: 301241437.xml
Lobbying Issues
-- H.R. 133 - Consolidated Appropriations Act, 2021: Ovarian Cancer Research Program at the Department of Defense; letters to Appropriations Committees; Peer-Reviewed Cancer Program at the Department of Defense: Add Endometrial Cancer to the list of eligible cancers, FY 2021 Report
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 133 - Consolidated Appropriations Act, 2021: FY 2021 Federal research funding for Gynecologic Cancer Clinical Trials in the Departments of Labor, HHS and Education Appropriations Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019: Prior Authorization Requirements in Medicare and Medicaid Advantage
-- H.R. 913 / S. 4742 - Medical Treatment Act: Coverage by Medicaid of clinical trials
-- H.R. 133 - Consolidated Appropriations Act, 2021; H.R. 8702 / S. 5007 - Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020; H.R. 8505 - To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes: Medicare Evaluation and Management Visits - Addressing the impact of E/M services updates on the future of the conversion factor and the payments for other Medicare services; discussions of various policy change proposals to address the budget neutrality of these payment changes
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on Oct. 19, 2020.
Original Filing: 301216080.xml
Lobbying Issues
-- H.R. 7617 - Department of Defense Appropriations Act, 2021: Ovarian Cancer Research Program at the Department of Defense. Letters to Appropriations Committee.
-- H. Rept. 116-453 to accompany H.R. 7617 - Peer-Reviewed Cancer Program at the Department of Defense: Add Endometrial Cancer to the list of eligible cancers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021: FY 2021 Federal research funding for Gynecologic Cancer Clinical Trials.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019: Prior Authorization Requirements in Medicare and Medicaid Advantage.
-- Medicare Evaluation and Management Visits -- Addressing the impact of E/M services updates on the future of the conversion factor and the payments for other Medicare services. Discussions of various policy change proposals to address the budget neutrality of these payment changes. H.R. 8505 - A bill to prevent pending Medicare cuts by waiving the budget neutrality requirements. Letter from Members of Congress to CMS and to House Leadership.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on July 20, 2020.
Original Filing: 301198290.xml
Lobbying Issues
-- H.R. 7617 - Department of Defense Appropriations Act, 2021: Ovarian Cancer Research Program at the Department of Defense.
-- H. Rept. 116-453 to accompany H.R. 7617 - Peer-Reviewed Cancer Program at the Department of Defense: Add Endometrial Cancer to the list of eligible cancers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021: FY 2021 Federal research funding for Gynecologic Cancer Clinical Trials.
-- H.R. 266 - Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800 - The Heroes Act: PPE and the Provider Relief Fund.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019: Prior Authorization Requirements in Medicare and Medicaid Advantage.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on April 20, 2020.
Original Filing: 301174632.xml
Lobbying Issues
-- FY 2021 Appropriations: Ovarian Cancer Research Program at the Department of Defense.
-- Peer-Reviewed Cancer Program at the Department of Defense: FY 2021 Report - add Endometrial Cancer to the list of eligible cancers.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- FY 2021 Federal research funding for Gynecologic Cancer Clinical Trials in the Departments of Labor, HHS and Education Appropriations Act.
-- H.R. 748 / S. 3548 - CARES Act; H.R. 6201 - Family First Coronavirus Response Act; H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020: COVID-19 Policies and Funding.
-- H.R. 3129 / S. 1735 - Jeanette Acosta Invest in Women's Health Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019: Prior Authorization Requirements in Medicare and Medicaid Advantage.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on Jan. 17, 2020.
Original Filing: 301110791.xml
Lobbying Issues
-- H.R. 1158 - FY2020 Consolidated Appropriations Act (Defense, CJS, FSGG, Homeland Security): Department of Defense Appropriations Act, 2020: Ovarian Cancer Research Program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 1865 - FY2020 Further Consolidated Appropriations Act (LHHSED, AG, Energy Water, Interior, Leg. Branch, MCVA, State-For. Ops, T-HUD): Department of Labor, HHS and Education Appropriations Act, 2020: Federal research funding for Gynecologic Cancer Clinical Trials.
-- H.R. 3129 / S. 1735 - Jeanette Acosta Invest in Women's Health Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019: Prior Authorization Requirements in Medicare and Medicaid Advantage.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on Oct. 21, 2019.
Original Filing: 301073501.xml
Lobbying Issues
-- H.R. 2968 / S. 2474 - Department of Defense Appropriations Act, 2020 / H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020: Ovarian Cancer Research Program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020: Federal research funding for Gynecologic Cancer Clinical Trials.
-- H.R. 3129 / S. 1735 - Jeanette Acosta Invest in Women's Health Act of 2019.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019: Prior Authorization Requirements in Medicare and Medicaid Advantage.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on July 22, 2019.
Original Filing: 301058962.xml
Lobbying Issues
-- H.R. 2968 - Department of Defense Appropriations Act, 2020 / H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020: Ovarian Cancer Research Program
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020: Federal research funding for Gynecologic Cancer Clinical Trials
-- H.R. 3129 / S. 1735 - Jeanette Acosta Invest in Women's Health Act of 2019
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 3107 - Improving Seniors' Timely Access to Care Act of 2019: Prior Authorization Requirements in Medicare and Medicaid Advantage
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on April 22, 2019.
Original Filing: 301037042.xml
Lobbying Issues
-- FY 2020 Appropriations for the Ovarian Cancer Research Program at the Department of Defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- FY 2020 Federal research funding for Gynecologic Cancer Clinical Trials in the Departments of Labor, HHS, and Education Appropriations Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on Jan. 22, 2019.
Original Filing: 301017040.xml
Lobbying Issues
-- H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019; S.3159 - Department of Defense Appropriations Act, 2019: FY 2019 funding for ovarian cancer research program at the Department of Defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 6470 / S. 3158 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019: FY 2019 research funding for Gynecologic Cancer Clinical Trials
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- CY 2019 Proposed Medicare Physician Fee Schedule - Proposal regarding office visit documentation and payments; congressional letters to Centers for Medicare and Medicaid Services (CMS)
-- CMS policy regarding Medicare Advantage and STEP Therapy Prior Authorization Programs for Medicare Part B drugs
-- CMS proposals on Drug Pricing Demonstration Program, comment to proposed notice
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on Oct. 19, 2018.
Original Filing: 300992623.xml
Lobbying Issues
-- H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019; S.3159 - Department of Defense Appropriations Act, 2019: FY 2019 funding for ovarian cancer research program at the Department of Defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 6470 / S. 3158 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R. 6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019: FY 2019 funding for ovarian cancer research program at the Department of Defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- CY 2019 Proposed Medicare Physician Fee Schedule - Proposal regarding office visit documentation and payments; congressional letters to Centers for Medicare and Medicaid Services (CMS)
-- CMS policy regarding Medicare Advantage and Step Therapy Prior Authorization Programs for Medicare Part B drugs
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on July 20, 2018.
Original Filing: 300975135.xml
Lobbying Issues
-- H.R. 6157 / S. 3159 - Department of Defense Appropriations Act, 2019: FY 2019 funding for ovarian cancer research program at the Department of Defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- House Subcommittee Draft / S. 3158 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019: FY 2019 federal research funding for gynecologic cancer clinical trials
-- S. 204 (became Public Law No. 115-176) - Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on April 19, 2018.
Original Filing: 300949992.xml
Lobbying Issues
-- H.R. 3219 - Make America Secure Appropriations Act, 2018; H.R. 1625 - Vehicle for Consolidated Appropriations Act 2018: FY 2018 funding for ovarian cancer research program at the Department of Defense
-- FY 2019 funding for ovarian cancer research program at the Department of Defense
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 1892 - Continuing Resolution: Changes to the Medicare Access and CHIP Reauthorization Act of 2016 regarding CMS flexibility for cost measures, penalties, Part B drugs, and PTAC
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on Jan. 22, 2018.
Original Filing: 300935775.xml
Lobbying Issues
-- H.R. 3219 - Department of Defense Appropriations Act, 2018: Funding for the Ovarian Cancer Research Program at the Department of Defense.
-- H.R. 1628 - American Health Care Act of 2017 / Senate Better Care Reconciliation Act of 2017: Essential benefits package, Medicaid expansion and coverage assistance.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2810 / S. 1519 - National Defense Authorization Act for Fiscal Year 2018: Protect funding and conduct of certain medical research and development projects by the Department of Defense.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on Oct. 20, 2017.
Original Filing: 300914139.xml
Lobbying Issues
-- H.R. 1301 - Department of Defense Appropriations Act, 2017: Funding for the Ovarian Cancer Research Program at the Department of Defense.
-- H.R. 3219 - Department of Defense Appropriations Act, 2018: Funding for the Ovarian Cancer Research Program at the Department of Defense.
-- H.R. 1628 - American Health Care Act of 2017 / Senate Better Care Reconciliation Act of 2017: Essential benefits package, Medicaid expansion and coverage assistance.
Agencies Lobbied
U.S. Senate
Lobbying Issues
S. 1519 - National Defense Authorization Act for Fiscal Year 2018: Durbin / Blunt Amendment (SA 592) to protect funding and conduct of certain medical research and development projects by the Department of Defense.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 20, 2017.
Original Filing: 300897713.xml
Lobbying Issues
-- H.R. 1301 - Department of Defense Appropriations Act, 2017: Funding for the Ovarian Cancer Research Program at the Department of Defense.
-- H.R. 3219 - Department of Defense Appropriations Act, 2018: Funding for the Ovarian Cancer Research Program at the Department of Defense.
-- H.R. 1628 - American Health Care Act of 2017 / Senate Better Care Reconciliation Act of 2017: Essential benefits package, Medicaid expansion and coverage assistance.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on April 20, 2017.
Original Filing: 300873648.xml
Lobbying Issues
-- H.R. 1301 - Department of Defense Appropriations Act, 2017: Funding for the Ovarian Cancer Research Program at the Department of Defense.
-- Department of Defense Appropriations Act, 2018: Funding for the Ovarian Cancer Research Program at the Department of Defense.
-- H.J. Res. 43 / S.J. Res. 13: A joint resolution providing for congressional disapproval under Chapter 8 of Title 5, United States Code, of the final rule submitted by the Secretary of Health and Human Services relating to compliance with Title X requirements by project recipients in selecting sub-recipients.
-- H.R. 1628 - American Health Care Act of 2017: Essential benefits package, Medicaid expansion and coverage assistance.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Jan. 23, 2017.
Original Filing: 300857662.xml
Lobbying Issues
H.R. 5293 / S. 3000 - Department of Defense Appropriations Act, 2017; H.R. 2028 - Further Continuing and Security Assistance Appropriations Act: FY 2017 funding for the Ovarian Cancer Research Program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; responses to Centers for Medicare & Medicaid Services requests for information regarding implementation.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $30,000. The report was filed on Oct. 20, 2016.
Original Filing: 300835518.xml
Lobbying Issues
H.R. 5293 / S. 3000 - Department of Defense Appropriations Act, 2017: FY 2017 funding for the Ovarian Cancer Research Program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; responses to Centers for Medicare & Medicaid Services requests for information regarding implementation; discussion with Center for Medicare & Medicaid Innovation regarding development of alternative payment models.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 20, 2016.
Original Filing: 300818104.xml
Lobbying Issues
H.R. 5293 / S. 3000 - Department of Defense Appropriations Act, 2017: FY 2017 funding for the Ovarian Cancer Research Program at the Department of Defense.
Amendments to S. 2943 - National Defense Authorization Act for Fiscal Year 2017: Effort to continue the Congressional Directed Research Program at the Department of Defense, including the Ovarian Cancer Research Program.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; comments in response to CMS proposed rule.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on April 19, 2016.
Original Filing: 300796913.xml
Lobbying Issues
FY 2017 funding for the ovarian cancer research program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Jan. 20, 2016.
Original Filing: 300784467.xml
Lobbying Issues
H.R.2029 - Consolidated Appropriations Act, 2016: Funding for the ovarian cancer research program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Oct. 20, 2015.
Original Filing: 300764165.xml
Lobbying Issues
H.R.2685/S.1558 - Department of Defense Appropriations Act, 2016: Funding for the ovarian cancer research program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015: Discussions regarding the resources for quality measures development included in the legislation.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 19, 2015.
Original Filing: 300740329.xml
Lobbying Issues
FY 2016 funding for the ovarian cancer research program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015: Halt the Medicare Physician Fee Schedule Final Rule provision to eliminate the 10- and 90-day global surgical packages, and repeal and replace the sustainable growth rate (SGR) with a new payment system.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.1735 - National Defense Authorization Act for Fiscal Year 2016, Senate Amendment 1485: Regarding limiting Defense Department medical research.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on April 20, 2015.
Original Filing: 300725431.xml
Lobbying Issues
FY 2016 funding for the ovarian cancer research program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015: Halt the Medicare Physician Fee Schedule Final Rule provision to eliminate the 10- and 90-day global surgical packages, and repeal and replace the sustainable growth rate (SGR) with a new payment system.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Jan. 20, 2015.
Original Filing: 300707628.xml
Lobbying Issues
H.R.83 - Consolidated and Further Continuing Appropriations Act, 2015: Support FY 2015 funding for the ovarian cancer research program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.83 - Consolidated and Further Continuing Appropriations Act, 2015: Halt the Medicare Physician Fee Schedule Final Rule provision to eliminate the 10- and 90-day global surgical packages.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Oct. 20, 2014.
Original Filing: 300683674.xml
Lobbying Issues
H.R. 4870 - Department of Defense Appropriations Act, 2015: Support FY 2015 funding for the ovarian cancer research program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 4015 / S. 2000 / S. 2110 / S. 2122 - SGR Repeal and Medicare Provider Payment Modernization Act of 2014: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
Meetings to discuss the CY 2015 Proposed Medicare Physician Fee Schedule and the proposals regarding global surgical periods for Current Procedural Terminology (CPT) codes and the proposed changes to the quality reporting programs.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 20, 2014.
Original Filing: 300663921.xml
Lobbying Issues
H.R. 4870 - Department of Defense Appropriations Act, 2015: Support FY 2015 funding for the ovarian cancer research program at the Department of Defense.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 4015 / S. 2000 / S. 2110 / S. 2122 - SGR Repeal and Medicare Provider Payment Modernization Act of 2014: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
Agencies Lobbied
U.S. Senate
1st Quarter, 2014
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on April 18, 2014.
Original Filing: 300641774.xml
Lobbying Issues
-- FY 2015 funding for the ovarian cancer research program at the Department of Defense.
-- Efforts in support of Dear Colleague letter to meet April 2nd House of Representatives deadline.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 4015 / S. 2000 / S. 2110 / S. 2122: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
-- H.R. 4302 - Protecting Access to Medicare Act of 2014: Legislation to halt Medicare cuts to physician payments for 12 months, until April 1, 2015.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Jan. 22, 2014.
Original Filing: 300628328.xml
Lobbying Issues
-- H.R. 3547 - Consolidated Appropriations Act, 2014: FY 2014 funding for the ovarian cancer research program
at the Department of Defense.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2810 - Medicare Patient Access and Quality Improvement Act of 2013 / S. __ - Original Bill to Repeal Sustainable Growth Rate System and to Consider Health Care Extenders: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.-- Senate Amendment to H.J. Res. 59 - Bipartisan Budget Act of 2013 and Pathway to SGR Reform Act of 2013: Legislation to address the SGR until March 31, 2014.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $10,000. The report was filed on Oct. 19, 2013.
Original Filing: 300601126.xml
Lobbying Issues
-- H.R. 2397 - Department of Defense Appropriations Act, 2014: FY 2014 funding for the ovarian cancer research program
at the Department of Defense.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Communications with relevant congressional committees regarding discussion drafts for legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 22, 2013.
Original Filing: 300586260.xml
Lobbying Issues
-- H.R. 2397 - Department of Defense Appropriations Act, 2014: Fiscal Year 2014 funding for the ovarian cancer research program
at the Department of Defense.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Communications with relevant congressional committees regarding discussion drafts for legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment, and the future of Medicare Physician Payment.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on April 22, 2013.
Original Filing: 300564270.xml
Lobbying Issues
-- H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013: FY 2013 funding for the ovarian cancer research program at the Department of Defense.
-- FY 2014 Funding for the ovarian cancer research program at the Department of Defense.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Examine solutions for Medicare system of reimbursement for physicians, including repeal of sustainable growth rate (SGR) and reform of physician payment.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Jan. 22, 2013.
Original Filing: 300542846.xml
Lobbying Issues
-- H.R. 5856 - Department of Defense Appropriations Act, 2013: Fiscal Year 2013 funding for the ovarian cancer research program
at the Department of Defense.
-- S. 3295 - Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2013:
Fiscal Year 2013 funding for the National Cancer Institute.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 8 - American Taxpayer Relief Act of 2012: Examine solutions to the Medicare system of reimbursement for physicians.
-- H.R. 452 - Medicare Decisions Accountability Act of 2011 / S. 668 - Health Care Bureaucrats Elimination Act: Examine repeal of
Independent Payment Advisory Board.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Oct. 22, 2012.
Original Filing: 300521007.xml
Lobbying Issues
-- H.R. 5856 - Department of Defense Appropriations Act, 2013: Fiscal Year 2013 funding for the ovarian cancer research program at the Department of Defense.
-- S. 3295 - Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2013:
Fiscal Year 2013 funding for the National Cancer Institute.-- S. 3187 - The Food and Drug Administration Safety and Innovation Act (Public Law 112-144): Legislation to reauthorize drug approval user fees and other Food and Drug Administration (FDA) policies regarding notification by manufacturers of impending drug shortages.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Examine solutions to the Medicare system of reimbursement for physicians.
-- General discussion on the elimination of cuts to coverage for medical imaging, specifically ultrasound services.
-- H.R. 452 - Medicare Decisions Accountability Act of 2011 / S. 668 - Health Care Bureaucrats Elimination Act: Examine repeal of Independent Payment Advisory Board.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2012
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 20, 2012.
Original Filing: 300494206.xml
Lobbying Issues
-- H.R. 5856 - Department of Defense Appropriations Act, 2013: Fiscal Year 2013 funding for the ovarian cancer research program at the Department of Defense.
-- S. 3295 - Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2013:
Fiscal Year 2013 funding for the National Cancer Institute.-- S. 3187 - The Food and Drug Administration Safety and Innovation Act: -- Reauthorization of drug approval user fees and other Food and Drug Administration (FDA) policies regarding notification by manufacturers of impending drug shortages.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Examine solutions to the Medicare system of reimbursement for physicians.
-- General discussion on the elimination of cuts to coverage for medical imaging, specifically ultrasound services.
-- H.R. 452 - Medicare Decisions Accountability Act of 2011 / S. 668 - Health Care Bureaucrats Elimination Act: Examine repeal of Independent Payment Advisory Board.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on April 20, 2012.
Original Filing: 300470556.xml
Lobbying Issues
-- Fiscal Year 2013 funding for the ovarian cancer research program at the Department of Defense.
-- Fiscal Year 2013 funding for the National Cancer Institute.
-- Reauthorization of drug approval user fees and other Food & Drug Administration policies regarding notification by manufacturers of impending drug shortages.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Examine solutions to the Medicare system of reimbursement for physicians.
-- General discussion on the elimination of cuts to coverage for medical imaging, specifically ultrasound services.
-- H.R. 452 - Medicare Decisions Accountability Act of 2011 / S. 668 - Health Care Bureaucrats Elimination Act: Examine repeal of Independent Payment Advisory Board.-- H.R. 3630 - Middle Class Tax Relief and Job Creation Act of 2012: Examine solutions for Medicare system of reimbursement for physicians.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Jan. 20, 2012.
Original Filing: 300449925.xml
Lobbying Issues
-- H.R. 2219 - Department of Defense Appropriations Act, 2012: Fiscal Year 2012 funding for the ovarian cancer research program at the Department of Defense.
-- Reintroduction of legislation regarding ovarian cancer biomarkers.-- H.R. 3070/S. 1599 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012: Fiscal Year 2012 funding for the National Cancer Institute.
-- H.R. 2055 (P.L. 112-74) - Consolidated Appropriations Act, 2012: Fiscal Year 2012 funding for the Department of Defense Ovarian Research Program and the National Cancer Institute.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Examine solutions to the Medicare system of reimbursement for physicians.
-- General discussion on the elimination of cuts to coverage for medical imaging, specifically ultrasound services.
-- H.R. 452 - Medicare Decisions Accountability Act of 2011 / S. 668 - Health Care Bureaucrats Elimination Act: Examine repeal of Independent Payment Advisory Board.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2011
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Oct. 20, 2011.
Original Filing: 300429489.xml
Lobbying Issues
-- H.R. 2219 - Department of Defense Appropriations Act, 2012: Fiscal Year 2012 funding for the ovarian cancer research program at the Department of Defense.
-- Reintroduction of legislation regarding ovarian cancer biomarkers.-- H.R. 3070/S. 1599 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012: Fiscal Year 2012 funding for the National Cancer Institute.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Examine solutions to the Medicare system of reimbursement for physicians.
-- General discussion on the elimination of cuts to coverage for medical imaging, specifically ultrasound services.
-- H.R. 452 - Medicare Decisions Accountability Act of 2011 / S. 668 - Health Care Bureaucrats Elimination Act: Examine repeal of Independent Payment Advisory Board.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 20, 2011.
Original Filing: 300405005.xml
Lobbying Issues
-- H.R. 2219 - Department of Defense Appropriations Act, 2012: Fiscal Year 2012 funding for the ovarian cancer research program at the Department of Defense.
-- Fiscal Year 2012 funding for the National Cancer Institute.
-- Reintroduction of legislation regarding ovarian cancer biomarkers.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2011
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on April 20, 2011.
Original Filing: 300379616.xml
Lobbying Issues
-- H.R. 1363, Further Additional Continuing Appropriations Amendments, 2011: FY 2011 research funding for gynecologic cancer research at the National Cancer Institute, FY 2011 funding for the ovarian cancer research program at the Department of Defense.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2010
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Jan. 20, 2011.
Original Filing: 300353797.xml
Lobbying Issues
-- H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011: FY 2011 funding for the National Cancer Institute, FY 2011 funding for the ovarian cancer research program at the Department of Defense.`
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 4994, Medicare and Medicaid Extenders Act of 2010: Medicare physician payment rates starting January 1, 2011, halting the cut of 25 percent.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2010
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Oct. 20, 2010.
Original Filing: 300328223.xml
Lobbying Issues
-- H.R. 3293, FY 2011 funding for gynecologic cancer research at the National Cancer Institute
-- H.R. 3326, FY 2011 funding for the Ovarian Cancer Research Program at the Department of Defense
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 3590, Patient Protection and Affordable Care Act: Implementation of prevention initiatives
-- H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010: Support 2.2 percent update to 2010 physician fee schedule for June 1 - November 30, 2010 period of service
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2010
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 20, 2010.
Original Filing: 300298873.xml
Lobbying Issues
-- H.R. 3293, FY 2011 funding for gynecologic cancer research at the National Cancer Institute
-- H.R. 3326, FY 2011 funding for the Ovarian Cancer Research Program at the Department of Defense
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 3590, Patient Protection and Affordable Care Act: Implementation of prevention initiatives
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2010
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on April 20, 2010.
Original Filing: 300273638.xml
Lobbying Issues
-- H.R. 3293, Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010: Funding at the National Cancer Institute for gynecologic cancer research
-- H.R. 3326, Department of Defense Appropriations Act, 2010: Funding for the Ovarian Cancer Research Program at the Department of Defense
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2590, Patient Protection and Affordable Care Act: Oppose Independent Medicare Commission; oppose budget neutral shift from all other services to pay for primary care bonus; support Medical Liability Reform Demonstrations; preserve reimbursement for ultrasound services; support PQRI program and other quality initiatives
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2009
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Jan. 20, 2010.
Original Filing: 300245120.xml
Lobbying Issues
-- HR 3293 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010: Funding at the National Cancer Institute for gynecologic cancer research
-- HR 3326 - Department of Defense Appropriations Act, 2010: Funding for the Ovarian Cancer Research Program at the Department of Defense
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- HR 3962 - Affordable Health Care for America Act (and predecessor, HR 3200): Preserve Medicare reimbursement for ultrasound services; oppose Independent Medicare Commission in Senate health care reform bill; accountable care organizations; Medical Liability Reform Demonstration projects-- HR 3961 - Medicare Physician Payment Reform Act of 2009: Support repeal of current formula for physician payment and replace with new system
-- HR 3590 - Patient Protection and Affordable Care Act: Oppose Independent Medicare Commission; oppose budget neutral shift from all other services to pay for primary care bonus; support Medical Liability Reform Demonstrations; preserve reimbursement for ultrasound services; PQRI program; other quality initiatives
-- S 1776 - Medicare Physician Fairness Act of 2009: Repeal current Medicare physician payment system
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2009
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Oct. 20, 2009.
Original Filing: 300221653.xml
Lobbying Issues
-- FY 2010 funding for the Ovarian Cancer Research Program at the Department of Defense.
-- FY 2010 funding at the National Cancer Institute for Gynecological Cancer Research.
-- S 755 / HR 1816 -- Ovarian Cancer Biomarker Research Act of 2009 and its incorporation under ALERT and House bill.
-- S 717 (21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act / discussion draft) -- Proposed edits to create a new research program for high-mortality cancers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- HR 3200 / previous discussion draft (America's Affordable Health Choices Act) -- Ensure that ultrasound practice expense equipment utilization rate is not cut in the final HR 3200 and Medicare physician reimbursement (including ACOs, SGR, Medical Home).-- America's Healthy Future Act / previous Finance Committee health care reform discussion papers -- Ensure that ultrasound practice expense equipment utilization rate is not cut in the final HR 3200 and Medicare physician reimbursement (including ACOs, SGR, Medical Home).
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2009
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 20, 2009.
Original Filing: 300193864.xml
Lobbying Issues
-- Fiscal Year 2010 funding for the Ovarian Cancer Research Program at the Department of Defense.
-- Fiscal Year 2010 funding for gynecological cancer research at the National Cancer Institute.
-- S 717: 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act and the House discussion draft (Reps. Capps/Pallone) - Proposed modifications to create a new research program for high-mortality cancers.-- HR 1816/S 755: Ovarian Cancer Biomarker Research Act of 2009 - Incorporation of legislation under ALERT and House bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- HR 2939: Oncology Quality Care Demonstration Project - Project to test the use of guideline-based medicine, coordination of care and end of life planning.
-- HR 3200: America's Affordable Health Choices Act and its previous discussion draft - Ensure that ultrasound practice expense equipment utilization rate is not cut in final HR 3200, and Medicare physician reimbursement (e.g., ACOs, SGR, Medical Home).-- Senate health care reform discussion papers - Ensure that ultrasound practice expense equipment utilization rate is not cut in the final HR 3200, and Medicare physician reimbursement (e.g., ACOs, SGR, Medical Home).
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2009
In Q1, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on April 20, 2009.
Original Filing: 300163550.xml
Lobbying Issues
-- FY 2010 funding for the Ovarian Cancer Research Program at the Department of Defense
-- FY 2010 funding for gynecologic cancer research at the National Cancer Institute
-- S. 755 / H.R. 1816 (Ovarian Cancer Biomarker Research Act of 2009)
-- S. 717 (21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act) -- Proposed edits to create a new research program for high-mortality cancers.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Policy conversations regarding Medicare physician payment reform.
-- Policy conversations regarding an Oncology Quality Care Demonstration Project that would test the use of guideline-based medicine, coordination of care and end of life planning.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2008
In Q4, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Jan. 21, 2009.
Original Filing: 300134051.xml
Lobbying Issues
HR 2638 (Consolidated Appropriations, 2009) - FY 2009 Funding for Ovarian Cancer Department of Defense Research Program
S 3230 - FY 2009 Funding for the National Cancer Institute
HR 3689 / S 2569 - Ovarian Cancer Biomarkers Research Act
21st Century Cancer ALERT Act of 2009 (Kennedy / Hutchison): draft policy ideas
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 6725 - Oncology Quality Care Demonstration Act of 2008: Medicare demonstration project to study how the use of cancer
treatment guidelines and EMRs can increase quality and reduce costs of comprehensive cancer care
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on Oct. 17, 2008.
Original Filing: 300098187.xml
Lobbying Issues
FY 2009 Funding for Ovarian Cancer Department of Defense Research Program
FY 2009 Funding for the National Cancer Institute
HR 3689 / S 2569 - Ovarian Cancer Biomarkers Research Act
Kennedy / Hutchison Omnibus National Cancer Program Improvement Act: draft policy ideas
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 6331 / S 3101 - Medicare Improvements for Patients and Providers Act of 2008: halt 10.6 percent cut in Medicare physician reimbursement before June 30th
HR 6725 - Oncology Quality Care Demonstration Act of 2008: Medicare demonstration project to study how the use of cancer
treatment guidelines and EMRs can increase quality and reduce costs of comprehensive cancer care
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, Galileo Consulting Group, Inc. lobbied for Society of Gynecologic Oncologists , earning $20,000. The report was filed on July 18, 2008.
Original Filing: 300073201.xml
Lobbying Issues
FY 2009 Funding for Ovarian Cancer Department of Defense Research Program
FY 2009 Funding for the National Cancer Institute
HR 3689 / S 2569 - Ovarian Cancer Biomarkers Research Act
Kennedy / Hutchison Omnibus National Cancer Program Improvement Act: draft policy ideas
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 6331 / S 3101 - Medicare Improvements for Patients and Providers Act of 2008: halt 10.6 percent cut in Medicare physician reimbursement before June 30th
Chemotherapy / Oncology Quality Care Demonstration Project under Medicare
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, Galileo Consulting Group, Inc. lobbied for Society for Gynecologic Oncologists , earning $20,000. The report was filed on April 21, 2008.
Original Filing: 300049000.xml
Lobbying Issues
FY 2009 Funding for Department of Defense Ovarian Cancer Research Program
FY 2009 Funding for the National Cancer Institute
HR 3689 / S 2569 Ovarian Cancer Biomarker Research Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Halt 10.6 percent cut in Medicare physician reimbursement before June 30th
Chemotherapy Demonstration Project under Medicare
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2005
Galileo Consulting Group, Inc. filed a lobbying registration on Feb. 7, 2008 to represent Society of Gynecologic Oncologists, effective July 1, 2005.
Original Filing: 300012025.xml
Issue(s) they said they’d lobby about: Increased research funding at the National Cancer Institute for gynecologic cancer; increased funding for Department of Defense Ovarian Cancer Research Program; Medicare reimbursement for patient care services provided by gynecologic oncologists, i.e., surgery, chemotherapy and office visits. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...